El Hoffy NM - Search Results

1

Computational Amendment of Parenteral In Situ Forming Particulates' Characteristics: Design of Experiment and PBPK Physiological Modeling.

El Hoffy NM, Yacoub AS, Ghoneim AM, Ibrahim M, Ammar HO, Eissa N. El Hoffy NM, et al. Pharmaceutics. 2023 Oct 23;15(10):2513. doi: 10.3390/pharmaceutics15102513. Pharmaceutics. 2023. PMID: 37896273 Free PMC article.

2

In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.

Ammar HO, Haider M, Ibrahim M, El Hoffy NM. Ammar HO, et al. Among authors: el hoffy nm. Drug Deliv. 2017 Nov;24(1):414-421. doi: 10.1080/10717544.2016.1259371. Drug Deliv. 2017. PMID: 28165822 Free PMC article.

3

Non-ionic Surfactant Based In Situ Forming Vesicles as Controlled Parenteral Delivery Systems.

Ammar HO, Ibrahim M, Mahmoud AA, Shamma RN, El Hoffy NM. Ammar HO, et al. Among authors: el hoffy nm. AAPS PharmSciTech. 2018 Apr;19(3):1001-1010. doi: 10.1208/s12249-017-0897-8. Epub 2017 Nov 6. AAPS PharmSciTech. 2018. PMID: 29110291

4

Artificial intelligence-assisted development of in situ forming nanoparticles for arthritis therapy via intra-articular delivery.

Yacoub AS, Ammar HO, Ibrahim M, Mansour SM, El Hoffy NM. Yacoub AS, et al. Among authors: el hoffy nm. Drug Deliv. 2022 Dec;29(1):1423-1436. doi: 10.1080/10717544.2022.2069882. Drug Deliv. 2022. PMID: 35532141 Free PMC article.

5

Cyclodextrin Stabilized Freeze-Dried Silica/Chitosan Nanoparticles for Improved Terconazole Ocular Bioavailability.

Zaghloul N, El Hoffy NM, Mahmoud AA, Elkasabgy NA. Zaghloul N, et al. Among authors: el hoffy nm. Pharmaceutics. 2022 Feb 22;14(3):470. doi: 10.3390/pharmaceutics14030470. Pharmaceutics. 2022. PMID: 35335847 Free PMC article.

6

PLGA-modified Syloid^®-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations.

Zaghloul N, Mahmoud AA, Elkasabgy NA, El Hoffy NM. Zaghloul N, et al. Among authors: el hoffy nm. Drug Deliv. 2022 Dec;29(1):2117-2129. doi: 10.1080/10717544.2022.2092239. Drug Deliv. 2022. PMID: 35838555 Free PMC article.

7

Computational Investigation to Design Ofloxacin-Loaded Hybridized Nanocellulose/Lipid Nanogels for Accelerated Skin Repair.

AbouSamra MM, El Hoffy NM, El-Wakil NA, Awad GEA, Kamel R. AbouSamra MM, et al. Among authors: el hoffy nm. Gels. 2022 Sep 16;8(9):593. doi: 10.3390/gels8090593. Gels. 2022. PMID: 36135305 Free PMC article.

8

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes.

Abdel Azim EA, Elkheshen SA, Hathout RM, Fouly MA, El Hoffy NM. Abdel Azim EA, et al. Among authors: el hoffy nm. Int J Nanomedicine. 2022 Jun 25;17:2753-2776. doi: 10.2147/IJN.S370192. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35782018 Free PMC article.

9

Development and optimization of amphiphilic self-assembly into nanostructured liquid crystals for transdermal delivery of an antidiabetic SGLT2 inhibitor.

Lotfy NM, Ahmed MA, El Hoffy NM, Bendas ER, Morsi NM. Lotfy NM, et al. Among authors: el hoffy nm. Drug Deliv. 2022 Dec;29(1):3340-3357. doi: 10.1080/10717544.2022.2144546. Drug Deliv. 2022. PMID: 36377493 Free PMC article.

10

Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities.

El Hoffy NM, Abdel Azim EA, Hathout RM, Fouly MA, Elkheshen SA. El Hoffy NM, et al. Eur J Pharm Sci. 2021 Mar 1;158:105648. doi: 10.1016/j.ejps.2020.105648. Epub 2020 Nov 21. Eur J Pharm Sci. 2021. PMID: 33227347 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters